Incretins Role in the Pathophysiology of Type 2 Diabetes Mellitus

被引:0
|
作者
Mythili, S., V [1 ]
机构
[1] Sree Balaji Med Coll & Hosp, Dept Biochem, Madras 600044, Tamil Nadu, India
关键词
Incretins; Insulin resistance; Type II Diabetes Mellitus; pathophysiology;
D O I
暂无
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Type 2 Diabetes Mellitus (T2DM) is characterized by the decreased responsiveness of tissues to insulin known as Insulin resistance. There may also be Insulin secretary defects in advanced stages. The insulin secretion is initiated by incretins, the two intestinal hormones namely, Glucose dependant Insulinotropic Polypeptide (GIP) & Glucagon like Polypeptide1(GLP-1). They are secreted when food enters the stomach. These hormones are shown to be reduced in T2DM. Hence, the probable role of Incretins in the pathophysiology of T2DM is reviewed here. Many number of studies have been undertaken on the physiology of Incretins and their role in causation of type2 diabetes mellitus. The literature analysis and compilation of results is given here. The level of incretins are much reduced in type 2 diabetes mellitus leading on to reduction in the secretion of insulin and elevation in the level of glucagon. Incretins are necessary to prevent the occurrence of Type 2 Diabetes Mellitus.
引用
收藏
页码:698 / 702
页数:5
相关论文
共 50 条
  • [41] Pathophysiology of prediabetes and treatment implications for the prevention of type 2 diabetes mellitus
    Bergman, Michael
    ENDOCRINE, 2013, 43 (03) : 504 - 513
  • [42] Mathematical Modeling and Simulations of the Pathophysiology of Type-2 Diabetes Mellitus
    Nani, Frank
    Jin, Mingxian
    2015 8TH INTERNATIONAL CONFERENCE ON BIOMEDICAL ENGINEERING AND INFORMATICS (BMEI), 2015, : 296 - 300
  • [43] DYSLIPIDEMIA IN DIABETES MELLITUS TYPE 2; PREVALENCE, PATHOPHYSIOLOGY, MANAGEMENT, AND TREATMENT
    Arfaj, Lama Khaled
    Fattani, Abdulelah Fareed
    Khamaj, Areen Jibreel
    Khamaj, Rawan Jabril
    Alnejaimi, Sultana Sedki H.
    Ismail, Hala Atif
    Al Tamimi, Mohammad Ghazi
    Elmoursi, Mohamed Maged Mohamed
    Saati, Amjad Mohammed
    Alyamani, Ghaday Ibrahim
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 5 (12): : 17022 - 17028
  • [44] Diabetic ketoacidosis in type 2 diabetes mellitus—pathophysiology and clinical presentation
    Stephen N Davis
    Guillermo E Umpierrez
    Nature Clinical Practice Endocrinology & Metabolism, 2007, 3 : 730 - 731
  • [45] Diabetic ketoacidosis in type 2 diabetes mellitus - pathophysiology and clinical presentation
    Davis, Stephen N.
    Umpierrez, Guillermo E.
    NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2007, 3 (11): : 730 - 731
  • [46] Pathophysiology of dyslipidemia in patients with metabolic syndrome or type 2 diabetes mellitus
    Verges, Bruno
    NUTRITION CLINIQUE ET METABOLISME, 2007, 21 (01): : 9 - 16
  • [47] Pathophysiology of prediabetes and treatment implications for the prevention of type 2 diabetes mellitus
    Michael Bergman
    Endocrine, 2013, 43 : 504 - 513
  • [48] The role of osteoprotegerin in type 2 diabetes mellitus
    O'Sullivan, E. P.
    Ashley, D.
    Devlin, N.
    Crowley, R.
    Agha, A.
    Thompson, C. J.
    O'Gorman, D.
    Smith, D.
    DIABETOLOGIA, 2007, 50 : S271 - S271
  • [49] Role of Magnesium in Type 2 Diabetes Mellitus
    Jianan Feng
    Heyuan Wang
    Zhe Jing
    Yue Wang
    Yanli Cheng
    Wanning Wang
    Weixia Sun
    Biological Trace Element Research, 2020, 196 : 74 - 85
  • [50] Role of Magnesium in Type 2 Diabetes Mellitus
    Feng, Jianan
    Wang, Heyuan
    Jing, Zhe
    Wang, Yue
    Cheng, Yanli
    Wang, Wanning
    Sun, Weixia
    BIOLOGICAL TRACE ELEMENT RESEARCH, 2020, 196 (01) : 74 - 85